Back
Fortress Biotech, Inc. 10K Form
Sell
39
FBIO
Fortress Biotech, Inc.
Last Price:
$2.76
Seasonality Move:
14.98%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive FBIO News And Ratings
See the #1 stock for the next 7 days that we like better than FBIO
FBIO Financial Statistics
Sales & Book Value
| Annual Sales: | $57.7M |
|---|---|
| Cash Flow: | $-6.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.80 |
| Price / Book: | 1.53 |
Profitability
| EPS (TTM): | -0.26770 |
|---|---|
| Net Income (TTM): | $-53.8M |
| Gross Margin: | $32.3M |
| Return on Equity: | -223.06% |
| Return on Assets: | -34.04% |
Fortress Biotech, Inc. Earnings Forecast
Key Fortress Biotech, Inc. Financial Ratios
-
The Gross Profit Margin over the past 17 years for FBIO is 56.06%.
-
The Selling, General & Administrative Expenses for FBIO have been equal to 152.11% of Gross Profit Margin.
-
The Research & Development expenses have been 98.62% of Revenue.
-
The Net Earning history of FBIO is -209.54% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 8 years.
Fortress Biotech, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | FBIO |
| CUSIP: | 34960Q |
| Website: | fortressbiotech.com |
Debt
| Debt-to-Equity Ratio: | 1.22 |
|---|---|
| Current Ratio: | 2.19 |
| Quick Ratio: | 1.93 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 6.7 |
FBIO Technical Analysis vs Fundamental Analysis
Sell
39
Fortress Biotech, Inc. (FBIO)
is a Sell
Is Fortress Biotech, Inc. a Buy or a Sell?
-
Fortress Biotech, Inc. stock is rated a SellThe current Fortress Biotech, Inc. [FBIO] share price is $2.75. The Score for FBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.